Citadel Advisors
NVLN

Citadel Advisors’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Citadel Advisors’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-119,560
Closed -$87K – 10345
2019
Q3 		$87K Buy
119,560
+27,723
+30% +$20.1K ﹤0.01% 8546
2019
Q2 		$72K Buy
91,837
+31,150
+51% +$34.7K ﹤0.01% 8630
2019
Q1 		$75K Buy
+60,687
New +$69.1K ﹤0.01% 8658
2018
Q4 		– Hold
0
– – – 10266
2018
Q1 		– Sell
-19,655
Closed -$61K – 9193
2017
Q4 		$61K Buy
+19,655
New +$94.5K ﹤0.01% 7572

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
DMK
David M. Knott $264M AUM 59.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return